Patient groups

Medicine concept
#Biomedical research #Clinical trials #Patient groups #Regulatory

Why patient access must keep pace for innovative medicines

Claus Zieler, Chief Commercial & Medical Affairs Officer, Astellas Pharma discusses the barriers preventing patients from accessing innovative medicines at the scale at which they’re being devleoped and approved.   Strong innovation, uneven access  Innovation in medicines is accelerating globally. In oncology, immunology, rare diseases, and other specialty areas, scientific advances are translating into more targeted… Read More

#Exclusive Content

#Big pharma #Funding #Patient groups #Pharmaceutical industry #University of Bath

Patient groups influenced by drug company funding, study finds

Action is needed to safeguard the independence of patient organisations and charities, according to the findings of a new study.  The study by the University of Bath, UK, Lund University, Sweden and Kozminski University, Poland, concludes that patient organisations and charities across Europe are at risk of… Read More

#Business & Investment #News